These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25153161)

  • 1. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
    PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis.
    Zhang L; Jiang Y; Jiao P; Deng X; Xie Y
    Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
    Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
    J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
    Liu W; Xu J; Zhang C
    Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
    Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
    Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.
    He WP; Zhou J; Cai MY; Xiao XS; Liao YJ; Kung HF; Guan XY; Xie D; Yang GF
    BMC Cancer; 2012 Sep; 12():437. PubMed ID: 23020525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD1L is a novel independent prognostic factor for gastric cancer.
    Su Z; Zhao J; Xian G; Geng W; Rong Z; Wu Y; Qin C
    Clin Transl Oncol; 2014 Aug; 16(8):702-7. PubMed ID: 24258459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2.
    He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF
    Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
    Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
    Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.
    Sala R; Esquer H; Kellett T; Kearns JT; Awolade P; Zhou Q; LaBarbera DV
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection.
    Hyeon J; Ahn S; Park CK
    Korean J Pathol; 2013 Feb; 47(1):9-15. PubMed ID: 23482400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
    Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
    Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
    Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHD1L: a novel oncogene.
    Cheng W; Su Y; Xu F
    Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
    Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
    Sasi W; Jiang WG; Sharma A; Mokbel K
    BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECK is not an independent prognostic marker for breast cancer.
    Gomes LR; Fujita A; Mott JD; Soares FA; Labriola L; Sogayar MC
    BMC Cancer; 2015 Oct; 15():660. PubMed ID: 26449734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.